aod9604 human clinical trials results fat loss AOD-9604 Results: Week-by-Week Timeline (2026) AOD 9604 Peptide for Fat

Specifically, it produces no IGF-1 elevation (avoiding proliferative concerns), no negative impact on glucose metabolism (avoiding diabetes risk), no fluid retention or edema, and no concerning patterns of joint pain that can occur with growth hormone

Many elderly patients develop atrophic gastritis or take proton pump inhibitors (PPIs) long-term, both of which can impair absorption

For someone with mild fatigue and slightly low blood levels, a conservative approach of one injection every four weeks might be sufficient

These injections contain Methionine, Inositol, Choline, and Vitamin B12, each playing a crucial role in the body's metabolic processes